FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912731625> ?p ?o ?g. }

• W2912731625 endingPage "68" @default.
• W2912731625 startingPage "57" @default.
• W2912731625 abstract "Lung cancer is the most common incident cancer and the leading cause of cancer death. In recent years, the development of tumor immunotherapy especially chimeric antigen receptor T (CAR-T) cell has shown a promising future. Epidermal growth factor receptor variant III (EGFRvIII) is a tumor-specific mutation expressed in various types of tumors and has been detected in non-small cell lung cancer with a mutation rate of 10%. Thus, EGFRvIII is a potential antigen for targeted lung cancer therapy. In this study, CAR vectors were constructed and transfected into virus-packaging cells. Then, activated T cells were infected with retrovirus harvested from stable virus-producing single clone cell lines. CAR expression on the surfaces of the T cells was detected by flow cytometry and Western blot. The function of CAR-T targeting EGFRvIII was then evaluated. The EGFRvIII-CAR vector was successfully constructed and confirmed by DNA sequencing. A stable virus-producing cell line was produced from a single clone by limited dilution. The culture conditions for the cell line, including cell density, temperature, and culture medium were optimized. After infection with retrovirus, CAR was expressed on more than 90% of the T cells. The proliferation of CAR-T cells were induced by cytokine and specific antigen in vitro. More importantly, EGFRvIII-CART specifically and efficiently recognized and killed A549-EGFRvIII cells with an effector/target ratio of 10:1 by expressing and releasing cytokines, including perforin, granzyme B, IFN-γ, and TNF-α. The in vivo study indicated that the metastasis of A549-EGFRvIII cells in mice were inhibited by EGFRvIII-CART cells, and the survival of the mice was significantly prolonged with no serious side effects. EGFRvIII-CART showed significantly efficient antitumor activity against lung cancer cells expressing EGFRvIII in vivo and in vitro. Therefore, CAR-T targeting EGFRvIII is a potential therapeutic strategy in preventing recurrence and metastasis of lung cancer after surgery." @default.
• W2912731625 created "2019-02-21" @default.
• W2912731625 creator A5016261953 @default.
• W2912731625 creator A5023746467 @default.
• W2912731625 creator A5026718619 @default.
• W2912731625 creator A5027880821 @default.
• W2912731625 creator A5028236367 @default.
• W2912731625 creator A5052561518 @default.
• W2912731625 creator A5056569663 @default.
• W2912731625 creator A5065361552 @default.
• W2912731625 creator A5070561281 @default.
• W2912731625 creator A5086232250 @default.
• W2912731625 date "2019-02-01" @default.
• W2912731625 modified "2023-10-15" @default.
• W2912731625 title "Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy" @default.
• W2912731625 cites W1567896933 @default.
• W2912731625 cites W1584994624 @default.
• W2912731625 cites W1964439453 @default.
• W2912731625 cites W1966087891 @default.
• W2912731625 cites W1981302308 @default.
• W2912731625 cites W1985981664 @default.
• W2912731625 cites W1991427076 @default.
• W2912731625 cites W2001327683 @default.
• W2912731625 cites W2008806930 @default.
• W2912731625 cites W2010842378 @default.
• W2912731625 cites W2013878898 @default.
• W2912731625 cites W2017019887 @default.
• W2912731625 cites W2045793286 @default.
• W2912731625 cites W2047205338 @default.
• W2912731625 cites W2094945699 @default.
• W2912731625 cites W2099561543 @default.
• W2912731625 cites W2101938482 @default.
• W2912731625 cites W2103744931 @default.
• W2912731625 cites W2105879190 @default.
• W2912731625 cites W2107806760 @default.
• W2912731625 cites W2112723216 @default.
• W2912731625 cites W2118796952 @default.
• W2912731625 cites W2124373740 @default.
• W2912731625 cites W2129000805 @default.
• W2912731625 cites W2134422640 @default.
• W2912731625 cites W2159542715 @default.
• W2912731625 cites W2164001237 @default.
• W2912731625 cites W2166503791 @default.
• W2912731625 cites W2272984102 @default.
• W2912731625 cites W2561662975 @default.
• W2912731625 cites W2738678436 @default.
• W2912731625 cites W2753207486 @default.
• W2912731625 cites W2770230492 @default.
• W2912731625 cites W2787621143 @default.
• W2912731625 cites W2801359883 @default.
• W2912731625 cites W2805860820 @default.
• W2912731625 cites W3141540903 @default.
• W2912731625 cites W4230689412 @default.
• W2912731625 doi "https://doi.org/10.1007/s11684-019-0683-y" @default.
• W2912731625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30721445" @default.
• W2912731625 hasPublicationYear "2019" @default.
• W2912731625 type Work @default.
• W2912731625 sameAs 2912731625 @default.
• W2912731625 citedByCount "27" @default.
• W2912731625 countsByYear W29127316252019 @default.
• W2912731625 countsByYear W29127316252020 @default.
• W2912731625 countsByYear W29127316252021 @default.
• W2912731625 countsByYear W29127316252022 @default.
• W2912731625 countsByYear W29127316252023 @default.
• W2912731625 crossrefType "journal-article" @default.
• W2912731625 hasAuthorship W2912731625A5016261953 @default.
• W2912731625 hasAuthorship W2912731625A5023746467 @default.
• W2912731625 hasAuthorship W2912731625A5026718619 @default.
• W2912731625 hasAuthorship W2912731625A5027880821 @default.
• W2912731625 hasAuthorship W2912731625A5028236367 @default.
• W2912731625 hasAuthorship W2912731625A5052561518 @default.
• W2912731625 hasAuthorship W2912731625A5056569663 @default.
• W2912731625 hasAuthorship W2912731625A5065361552 @default.
• W2912731625 hasAuthorship W2912731625A5070561281 @default.
• W2912731625 hasAuthorship W2912731625A5086232250 @default.
• W2912731625 hasBestOaLocation W29127316251 @default.
• W2912731625 hasConcept C121608353 @default.
• W2912731625 hasConcept C147483822 @default.
• W2912731625 hasConcept C153911025 @default.
• W2912731625 hasConcept C159047783 @default.
• W2912731625 hasConcept C203014093 @default.
• W2912731625 hasConcept C2776090121 @default.
• W2912731625 hasConcept C2777701055 @default.
• W2912731625 hasConcept C2779438470 @default.
• W2912731625 hasConcept C3875195 @default.
• W2912731625 hasConcept C502942594 @default.
• W2912731625 hasConcept C54355233 @default.
• W2912731625 hasConcept C86803240 @default.
• W2912731625 hasConcept C8891405 @default.
• W2912731625 hasConceptScore W2912731625C121608353 @default.
• W2912731625 hasConceptScore W2912731625C147483822 @default.
• W2912731625 hasConceptScore W2912731625C153911025 @default.
• W2912731625 hasConceptScore W2912731625C159047783 @default.
• W2912731625 hasConceptScore W2912731625C203014093 @default.
• W2912731625 hasConceptScore W2912731625C2776090121 @default.
• W2912731625 hasConceptScore W2912731625C2777701055 @default.
• W2912731625 hasConceptScore W2912731625C2779438470 @default.
• W2912731625 hasConceptScore W2912731625C3875195 @default.

• next